These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer. Waseda N, Kato Y, Imura H, Kurata M. Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064 [Abstract] [Full Text] [Related]
9. [Steroid hormone receptors and survival in breast cancer patients]. Ivanova OA, Tsyrlina EV, Moiseenko VM, Semiglazov VF. Vopr Onkol; 1986 Nov; 32(6):71-6. PubMed ID: 3727485 [Abstract] [Full Text] [Related]
10. Relationship between PRL levels and steroid receptors in breast cancer. Marugo M, Fazzuoli L, Bernasconi D, Berta S, Giordano G. Anticancer Res; 1988 Nov; 8(4):819-23. PubMed ID: 3178171 [Abstract] [Full Text] [Related]
13. Association between prognosis and hormone receptors in women with breast cancer. Papatestas AE, Miller SR, Pertsemlidis D, Fagerstrom R, Lesnick G, Aufses AH. Cancer Detect Prev; 1986 Nov; 9(3-4):303-10. PubMed ID: 3742506 [Abstract] [Full Text] [Related]
14. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer. Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kücücük S, Aslay I, Aydiner A, Topuz E. Cancer Invest; 2008 Aug; 26(7):671-9. PubMed ID: 18608215 [Abstract] [Full Text] [Related]
15. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brünner N, Jänicke F, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WL, Klijn JG. Cancer Res; 2000 Feb 01; 60(3):636-43. PubMed ID: 10676647 [Abstract] [Full Text] [Related]
17. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients. Liu ZB, Liu GY, Yang WT, Di GH, Lu JS, Shen KW, Shen ZZ, Shao ZM, Wu J. Oncol Rep; 2008 Oct 01; 20(4):987-94. PubMed ID: 18813844 [Abstract] [Full Text] [Related]
18. Tree-based model for breast cancer prognostication. Banerjee M, George J, Song EY, Roy A, Hryniuk W. J Clin Oncol; 2004 Jul 01; 22(13):2567-75. PubMed ID: 15226324 [Abstract] [Full Text] [Related]
19. Negative margin status improves local control in conservatively managed breast cancer patients. Obedian E, Haffty BG. Cancer J Sci Am; 2000 Jul 01; 6(1):28-33. PubMed ID: 10696736 [Abstract] [Full Text] [Related]
20. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. Gasparini G, Toi M, Miceli R, Vermeulen PB, Dittadi R, Biganzoli E, Morabito A, Fanelli M, Gatti C, Suzuki H, Tominaga T, Dirix LY, Gion M. Cancer J Sci Am; 1999 Jul 01; 5(2):101-11. PubMed ID: 10198732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]